USD 69.5 billion
Global Biobanking Market Size, Share, Growth Analysis, By Type(Population-based Biobanks, Disease-based Biobanks), By Sample(Blood Products, Cell Lines), By Application(Drug Discovery, Genomic Research) - Industry Forecast 2024-2031
Report ID:
SQMIG35H2200 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|
Tables:
98 |
Figures:
76
Global Biobanking Market Insights
Global Biobanking Market size was valued at USD 69.5 billion in 2022 and is poised to grow from USD 72 billion in 2023 to USD 95.5 billion by 2031, growing at a CAGR of 6.8% in the forecast period (2024-2031).
In current years, the worldwide biobanking marketplace is experiencing considerable increase via means of growing biomedical studies, sports and a growing emphasis on personalized remedy.
Biobanks play a vital function in storing and dealing with organic samples, contributing to improvements in genomics, drug discovery, and sickness studies.
The developing occurrence of persistent sicknesses and the want for large-scale pattern collections for scientific trials similarly propel marketplace expansion. However, demanding situations consist of moral concerns, standardization issues, and the excessive value of biobanking infrastructure.
Regionally, North America dominates the marketplace, due to sturdy studies, infrastructure and substantial investments in healthcare. Key traits consist of a focal point on increasing pattern range and the combination of superior technology for green pattern upkeep and retrieval.
As the call for precision remedy and biomarker discovery rises, the biobanking marketplace is poised for sustained increase.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
Disease-based Biobanks
Fastest Growth
Population-based Biobanks
Growth Rate
6.8% CAGR
Global Biobanking Market ($ Bn)
Country Share for North America Region (%)
Global BiobankingMarket By Type ($ Bn)
Global BiobankingMarket By Type (%)
To get more reports on the above market click here to Buy The Report
Global Biobanking Market Segmental Analysis
The global biobanking market is segmented into four major segments i.e. by type of biobank, sample type, application, and region. Based on type, it is divided into population-based biobanks, disease-based biobanks, academic biobanks, hospital-based biobanks, and others. Based on sample type, it is bifurcated as blood products, cell lines, nucleic acids, human tissues, biofluids, and others. Based on application it is segregated into, drug discovery, genomic research, personalized medicine, regenerative medicine, disease research, and others. Based on region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East & Africa.
Analysis by Type
Disease-primarily based totally biobanks are in all likelihood to dominate the marketplace because of the growing awareness on know-how the genetic foundation of numerous diseases. These biobanks play a pivotal position in analyzing precise conditions, allowing researchers and pharmaceutical agencies to increase centered cures and customized medicinal drugs. The emphasis on precision medicinal drugs and the want for complete ailment-precise pattern collections make a contribution to the dominance of ailment-primarily based totally biobanks.
Population-primarily based totally biobanks are anticipated to be the quickest developing segment. These biobanks keep samples from a huge and various populace, presenting a treasured aid for epidemiological studies, biomarker discovery, and populace fitness research. As customized medicinal drug advances, researchers require considerable datasets representing various genetic backgrounds, making populace-primarily based totally biobanks an increasing number of crucial. The capability for figuring out genetic elements influencing ailment susceptibility and remedy reaction fuels the speedy increase of this biobank type.
Analysis by Application
Genomic research is poised to dominate the market as the demand for understanding the genetic basis of diseases and the development of precision medicine intensifies. Biobanks play a central role in providing diverse and comprehensive genetic samples, supporting extensive genomic studies that contribute to advancements in diagnostics, drug development, and personalized healthcare.
Personalized medicine is expected to be the fastest growing application segment. With a growing emphasis on tailoring medical treatment to individual characteristics, including genetic makeup, biobanks become instrumental in storing diverse samples for research aimed at identifying biomarkers and genetic variations. The increasing focus on targeted therapies and the integration of genomic information into clinical decision-making drive the rapid growth of personalized medicine applications in biobanking.
Global BiobankingMarket By Type, 2023 (%)
To get detailed analysis on other segments, Request For Free Sample Report
Global Biobanking Market Regional Insights
North America is poised to dominate the biobanking marketplace. This dominance is attributed to the presence of superior healthcare infrastructure, enormous investments in studies and development, and an excessive occurrence of continual diseases. Moreover, the place has advantages from robust collaborations among instructional institutions, pharmaceutical companies, and studies organizations, fostering an surroundings conducive to biobanking activities.
The Asia-Pacific place is predicted to be the quickest developing marketplace for biobanking. Factors along with a big and various population, growing occurrence of continual diseases, and growing investments in healthcare infrastructure make a contribution to the place's fast increase. Additionally, a developing consciousness on genomics studies, customized medicine, and a surge in medical trials similarly gas the call for biobanking offerings withinside the Asia-Pacific, making it a key increase place withinside the international biobanking marketplace.
- Largest
- Fastest
Global Biobanking Market By Region
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Global Biobanking Market Dynamics
Drivers
Increasing biomedical research activities
- The increasing biomedical research activities, particularly in genomics and personalized medicine, play a pivotal role in driving the demand for biobanking services. The rising prevalence of chronic diseases and the need for large-scale sample collections for clinical trials further contribute to the market's expansion. Additionally, the growing awareness of the potential of biobanks to advance scientific understanding, drug discovery, and disease research fuels the adoption of biobanking services globally. With the continuous evolution of precision medicine and the increasing importance of biomarker discovery, the biobanking market is expected to witness continued growth, driven by these fundamental drivers.
Restraints
High Ethical Concerns Surrounding the Collection of Biological Samples
- One of the main market restraints is the ethical concerns surrounding the collection and storage of biological samples, particularly in relation to consent and privacy, pose a significant challenge. Standardization issues across different biobanks and geographical regions can hinder interoperability and data sharing, limiting the effectiveness of collaborative research efforts. The substantial costs associated with establishing and maintaining biobanking infrastructure also act as a restraint, especially for smaller research institutions. Moreover, concerns related to the long-term sustainability of stored samples and the potential for sample degradation over time necessitate robust quality control measures.
Request Free Customization of this report to help us to meet your business objectives.
Global Biobanking Market Competitive Landscape
The competitive environment of the Biobanking market is dynamic and characterized by the presence of several key players engaging in strategic initiatives to solidify their market position. Established companies often focus on expanding their service offerings, investing in advanced technologies, and forming partnerships with research institutions and pharmaceutical companies. Additionally, mergers and acquisitions play a role in enhancing capabilities and extending geographic reach. The market's dynamism is further fueled by the entry of new players, particularly in emerging regions, contributing to increased competition.
Top Player’s Company Profiles
- AMS Biotechnology (Europe) Ltd.
- ASKION GmbH
- Avantor, Inc.
- Azenta, Inc. (Azenta)
- Bay Biosciences LLC
- BioIVT & Elevating Science
- Boca Biolistics
- CTI Biotech
- Cureline Inc.
- Firalis SA
- Geneticist Inc.
- Hamilton Bonaduz AG
- Isenet Biobanking
- Merck & Co., Inc.
- ProteoGenex Inc.
- Qiagen NV
- Stemcell Holdings, Inc.
- STEMCELL Technologies Inc.
- Thermo Fisher Scientific Inc.
- US Biolab Corp. Inc.
Recent Developments
- In July 2023, A revised Swedish Biobank Act was implemented, marking a contemporary update to the existing legislation. While maintaining its core objective of regulating the collection, storage, and ethical usage of identifiable human biological material for approved purposes, the new act addresses and clarifies uncertainties present in the original 2003 law. This modernization aims to enhance the understanding and interpretation of the regulations governing biobanking practices in Sweden.
- In June 2023, Denmark, Lithuania, and Switzerland received official confirmation of their membership in the Biobanking and BioMolecular resources Research Infrastructure – European Research Infrastructure Consortium (BBMRI-ERIC). Lithuania and Switzerland transitioned from being Observers to attaining full Membership status, while Denmark has newly joined as an Observer.
Global Biobanking Key Market Trends
Rising Adoption of Advanced Technologies
- The increasing adoption of advanced technologies, such as automated sample storage systems and blockchain, to enhance the efficiency and security of biobanking operations. Additionally, there is a growing emphasis on expanding the diversity of stored samples to encompass various demographic groups, promoting more inclusive and representative research outcomes. The integration of artificial intelligence (AI) and machine learning for data analysis and interpretation is another key trend, facilitating more in-depth insights from stored biological samples.
Global Biobanking Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
Global biobanking market analysis reveals a dynamic marketplace with a number of standout trends and difficulties. The market is propelled by increasing biomedical research demand, especially in genomics and personalized medicine. However, ethical concerns, standardization issues, and high infrastructure costs restrain its growth. Dominated by disease-based biobanks, the market sees genomic research as a dominant application. North America leads due to robust healthcare infrastructure, while Asia-Pacific exhibits the fastest growth owing to a rising population and healthcare investments. Trends include a focus on advanced technologies, diversified sample collections, and the integration of artificial intelligence, reflecting an evolving landscape aligned with the demands of precision medicine and global collaboration.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 69.5 billion |
| Market size value in 2031 | USD 95.5 billion |
| Growth Rate | 6.8% |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Global Biobanking Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Global Biobanking Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Global Biobanking Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global Biobanking Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global Biobanking Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Global Biobanking Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Global Biobanking Market Report Snapshots
Want to customize this report?
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
